Interview: Amon van den Borg, CEO, Arts en Zorg

Arts en Zorg is the only major pureplay primary care group in the Netherlands. CEO Amon van den Borg talks to HBI about its business model and plans for the future, and reflects on the need for modernisation and digitization within the Dutch healthcare sector.

Interview: Bart Malenstein, CEO, Quin

Dutch telehealth company Quin recently sold seven of its 11 physical GP practices with plans to sell the remaining four. CEO Bart Malenstein tells HBI that the company will instead focus on a licensing model to make its digital platform available to operators. This includes plans to expand into more specialist care and into other countries. 

Interview: Alexandra Prieux, CEO, ALCEDIAG

A pioneering blood test which helps clinicians diagnose bipolar disorder will come to market shortly. HBI catches up with Alexandra Prieux, CEO at France-based ALCEDIAG, which should be first to market with the first of what could be a series of tests.

Interview with Sandro Cilurzo, CEO & Co-Founder of Sedimentum

We hear a lot about digital and artificial intelligence (AI) technology shaking up the healthcare sector. Usually, these innovations focus on digital platforms and innovative surgery techniques, and elder care rarely gets much of a look in when conversations about AI start. However, some companies are bucking that trend by using AI to detect falls, and more, in residential and elderly care settings. We talk to Sandro Cilurzo, CEO & Co-Founder of Swiss healthcare start-up Sedimentum, to find out more.

Proximie continues global expansion with Teladoc deal

Since we last interviewed health-tech provider Dr Nadine Hachach-Haram, the Proximie CEO, last year, the group's technology has been deployed in 200 additional hospitals globally, and it has plans to scale its services up following its recent partnership with telehealth rival, Teladoc Health. HBI speaks to Hachach-Haram to find out more.

Interview: Dr James Mackay, medical director, Everything Genetic

UK genetic testing provider Everything Genetic has launched a new at-home predictive genetic testing service. HBI catches up with Dr James Mackay, medical director, to talk about the company’s plans for growth and the at home testing market.

Interview: Jalil Allabadi, CEO, Altibbi

Saudi Arabia’s largest telemedicine consultations platform Altibbi has managed to double its revenue for fifth consecutive year. CEO and founder Jalil Labadi shares the secrets behind this success with HBI, and talks strategy as the company develops.

HBI Interview: Carlos Nueno, President, International, Teladoc 

How fast is the world outside America adopting telehealth and digital care in all its forms? Who better to ask than Carlos Nueno, president International for Teladoc Health, which ties with Ping An from China for the title of the world’s largest telehealth operator. So, what new business models are being rolled out and when? And how are countries adopting the new technology?

Interview: Maris Revalds, Chairman, Health Center 4

Anyone paying attention to the Baltic healthcare market - and at just six million people you'd be forgiven for not - will have noticed an aggressive consolidation of the sector by pharmacy chain & wholesaler, Repharm; something rarely seen elsewhere. Health Center 4 (Veselības centrs 4) is the second-largest to it in Latvia and chairman Revalds speaks on his competitor's moves while also giving us an overview of his business and the local market.

Interview: Giuseppe Recchi, CEO, Affidea

Europe’s largest imaging company Affidea wants to become a one-stop shop for all outpatient services. HBI talks to CEO Giuseppe Recchi about changing a brand’s reputation, a record year of M&A and how the pandemic impacted the business.

Find Us